Beam Therapeutics
Latest round
- Series B
Last raised
- Mar 2019
Total raised
- $174M
Investors
- 9
About Beam Therapeutics
Beam Therapeutics Inc.Founded in 2017 and headquartered in Cambridge, US, Beam Therapeutics Inc. focuses on precision genetic medicine, particularly base editing for genetic disorders. The company has engaged in a total of four deals since its inception.Beam Therapeutics specializes in precision genetic medicines, particularly through an innovative approach known as base editing. Their core product offerings are designed to address the limitations of traditional genetic modification techniques, providing targeted solutions for various genetic disorders. The company's primary focus is on developing and commercializing therapies that can correct genetic mutations at a single base pair level, which could potentially transform the treatment landscape for diseases such as sickle cell disease and beta-thalassemia. Beam Therapeutics employs a suite of delivery technologies, including electroporation and both nonviral and viral delivery methods, to optimize the administration of their therapies.52 mn. The company generated this revenue through collaborations and partnerships with pharmaceutical companies and research institutions, focusing on the development and commercialization of its base editing technology. The company is actively designing new products aimed at addressing additional genetic disorders, with plans to launch these therapies in the next few years. Furthermore, Beam has identified international markets for expansion, specifically targeting Europe and Asia, by the end of 2025.
Who invested in Beam Therapeutics
9 investors across 2 rounds
See all investors in Beam Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beam Therapeutics
Who invested in Beam Therapeutics?
Beam Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beam Therapeutics raised?
Beam Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beam Therapeutics last raise money?
Beam Therapeutics's most recent round on record is a Series B, in Mar 2019.
What does Beam Therapeutics do?
Beam Therapeutics is a biotechnology company.
Where is Beam Therapeutics headquartered?
Beam Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Beam Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Beam Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Beam Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.